日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Synergistic anti-tumor activity of ciclopirox olamine and metformin in triple-negative breast cancer

环吡咯烷酮和二甲双胍在三阴性乳腺癌中的协同抗肿瘤活性

期刊:Genes and Diseases
影响因子:
doi:10.1016/j.gendis.2025.101538
Wu, Yakun; Lyu, Hui; Tan, Congcong; Larsen, Margaret E; Tang, Shou-Ching; Huang, Shile; Liu, Bolin
肿瘤
肿瘤免疫
乳腺癌
发表日期：2026
文献求助 收藏

HER3 promotes triple-negative breast cancer progression by upregulating PHF8 via miR-34b-5p-dependent mechanism.

HER3 通过 miR-34b-5p 依赖性机制上调 PHF8，从而促进三阴性乳腺癌的进展。

期刊:Cell Death & Disease
影响因子:9.6
doi:10.1038/s41419-025-08115-9
Lyu Hui, Tan CongCong, Wu Yakun, Larsen Margaret E, Yu Qingzhao, Kang Guobin, Wood Charles, Tang Shou-Ching, Liu Bolin
乳腺癌
肿瘤
PHF8
发表日期：2025
文献求助 收藏

Cable Cars to the Nucleus: TM4SF1-Enriched Microdomains Conduct Signaling in Endothelial Cells for Blood Vessel Formation

通往细胞核的缆车：富含TM4SF1的微区在内皮细胞中传导信号以促进血管形成

期刊:International Journal of Molecular Sciences
影响因子:4.9
doi:10.3390/ijms262110491
Jaminet, Shou-Ching
信号转导
细胞生物学
内皮细胞
发表日期：2025
文献求助 收藏

First-in-human phase I open-label study of the anti-TIM-3 monoclonal antibody INCAGN02390 in patients with select advanced or metastatic solid tumors

首次人体 I 期开放标签研究，评估抗 TIM-3 单克隆抗体 INCAGN02390 对特定晚期或转移性实体瘤患者的疗效

期刊:Oncologist
影响因子:4.2
doi:10.1093/oncolo/oyaf144
Gutierrez, Martin E; Tang, Shou-Ching; Powderly, John D 2nd; Balmanoukian, Ani S; Hoyle, Paul E; Dong, Zhiwan; Cheng, Lulu; Gong, Xiaohua; Janik, John E; Bourayou, Nawel; Hamid, Omid
单克隆抗体
TIM
发表日期：2025
文献求助 收藏

Beyond checkpoint inhibitors: the three generations of immunotherapy

超越免疫检查点抑制剂：免疫疗法的三代发展

期刊:Clinical and Experimental Medicine
影响因子:3.5
doi:10.1007/s10238-024-01546-2
Schaub, John; Tang, Shou-Ching
免疫/内分泌
发表日期：2025
文献求助 收藏

EA1211: interim FDG-PET/CT for predicting response of HER2-positive breast cancer to neoadjuvant therapy (DIRECT trial)

EA1211：FDG-PET/CT 中期研究预测 HER2 阳性乳腺癌对新辅助治疗的反应（DIRECT 试验）

期刊:Future Oncology
影响因子:2.6
doi:10.1080/14796694.2025.2567840
Hennessy, Maeve A; Gatsonis, Constantine; Jacene, Heather; Connolly, Roisin M; Burnette, Brian L; Stringer-Reasor, Erica M; Romanoff, Justin; Taurone, Alexander; O'Sullivan, Ciara C; Le-Petross, Huong T; Stearns, Vered; Fowler, Amy M; Tang, Shou-Ching; Sepulveda, Karla A; DeMichele, Angela M; Mankoff, David A; Wolff, Antonio C
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2025
文献求助 收藏

Influence of antibody-drug conjugate cleavability, drug-to-antibody ratio, and free payload concentration on systemic toxicities: A systematic review and meta-analysis

抗体药物偶联物裂解性、药物抗体比和游离有效载荷浓度对全身毒性的影响：系统评价和荟萃分析

期刊:Cancer and Metastasis Reviews
影响因子:8.7
doi:10.1007/s10555-024-10231-5
Tang, Shou-Ching; Wynn, Carrie; Le, Tran; McCandless, Martin; Zhang, Yunxi; Patel, Ritesh; Maihle, Nita; Hillegass, William
毒理研究
发表日期：2024
文献求助 收藏

Refining the optimal CAF cluster marker for predicting TME-dependent survival expectancy and treatment benefits in NSCLC patients

改进最佳 CAF 簇标记，以预测 NSCLC 患者的 TME 依赖性生存预期和治疗效益

期刊:Scientific Reports
影响因子:3.8
doi:10.1038/s41598-024-55375-0
Kai Li #, Rui Wang #, Guo-Wei Liu #, Zi-Yang Peng, Ji-Chang Wang, Guo-Dong Xiao, Shou-Ching Tang, Ning Du, Jia Zhang, Jing Zhang, Hong Ren, Xin Sun, Yi-Ping Yang, Da-Peng Liu
信号转导
发表日期：2024
文献求助 收藏

TM4SF1 is a molecular facilitator that distributes cargo proteins intracellularly in endothelial cells in support of blood vessel formation

TM4SF1 是一种分子促进剂，可将货物蛋白分布在内皮细胞内，以支持血管形成

期刊:Journal of Cell Communication and Signaling
影响因子:3.6
doi:10.1002/ccs3.12031
Chi-Iou Lin, Anne Merley, Shou-Ching S Jaminet
免疫
细胞生物学
内皮细胞
发表日期：2024
文献求助 收藏

Transmembrane-4 L-Six Family Member-1 Is Essential for Embryonic Blood Vessel Development

跨膜蛋白-4 L-Six 家族成员-1 对胚胎血管发育至关重要

期刊:Current Issues in Molecular Biology
影响因子:3
doi:10.3390/cimb46110781
Lin, Chi-Iou; Merley, Anne; Wada, Hiromi; Zheng, Jianwei; Jaminet, Shou-Ching S
发育与干细胞
发表日期：2024
文献求助 收藏